Cargando…
Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer
Salinomycin (Sal) is a recently identified anti-tumor drug for treating several types of solid tumor; however, its effects on the migratory and invasive properties of non-small cell lung cancer (NSCLC) remain unclear. This study investigated the inhibitory effect underlying mechanisms of Salon trans...
Autores principales: | Hwang, Ki-Eun, Kim, Hyo-Jin, Song, In-Sol, Park, Chul, Jung, Jae Wan, Park, Do-Sim, Oh, Seon-Hee, Kim, Young-Suk, Kim, Hak-Ryul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797542/ https://www.ncbi.nlm.nih.gov/pubmed/33437206 http://dx.doi.org/10.7150/ijms.50080 |
Ejemplares similares
-
Inhibition of MMP1, MMP2 and MMP8 by mepacrine
por: Pollaschek, C, et al.
Publicado: (2003) -
Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in Ductal Carcinoma in Situ and Invasive Ductal Carcinoma of the Breast
por: Kim, Hee Jung, et al.
Publicado: (2006) -
NOGO-B promotes EMT in lung fibrosis via MMP14 mediates free TGF-beta1 formation
por: Xiong, Ye, et al.
Publicado: (2017) -
TIMP-1 Induces an EMT-Like Phenotypic Conversion in MDCK Cells Independent of Its MMP-Inhibitory Domain
por: Jung, Young Suk, et al.
Publicado: (2012) -
MMP-1, MMP-3 and MMP-10 are involved in the degradation of cartilage
por: Tolboom, TCA, et al.
Publicado: (2001)